709 results found.
                    
BARE BONES® - March 3, 2015
A Court of Appeals for the Federal Circuit overturned the damages award in NuVasive's (NUVA) ongoing patent lawsuit with Medtronic and Warsaw Orthopedic.The court upheld a fin...
BARE BONES® - February 17, 2015
Medtronic reported 3Q15 (ended 1/23/15) spinal revenue of US $740MM, +2% vs. 3Q14. (U.S. $522MM, +1%, ex-U.S. $218MM, +4%; Core Spine $543MM, +1%; Interventional Spine...
2014 Revenue: Medtronic
(for the period ended 1/23/15) $740MM, +2% (U.S. $522MM, +1%, ex-U.S. $218MM, +4%) Core Spine $543MM, +1% (U.S. $359MM, -1%; ex-U.S. $184MM, +5%) Interventional Spine (primarily balloon kyphoplasty) $75MM, flat (U.S. $56MM, +2%, ex-U.S. $19MM, -5%)...
BARE BONES® - February 16, 2015
Medtronic received FDA 510(k) clearance for expanded indications of the VERTEX® Reconstruction System, allowing for lateral mass and pedicle screws to be used as fixation to treat various pat...
BARE BONES® - January 27, 2015
Medtronic completed its acquisition of Covidien. (Medtronic plc, 1/26/15)
Business Development Execs Speak on M&A and Innovation
Merger and acquisition activity amongst large and medium players dominated business development talk in 2014. Trends driving consolidation of all sizes related to new technology, process efficiency and international expansion. Business development leaders from Biomet, Smith & Nephew and Medtro...
2014: A Recap of Strategic Activities
To begin 2015, let’s look back at what fueled growth in 2014. Here, we present companies that ha...
2014: A Recap of Strategic Activities in Fracture Repair
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begi...
2014: A Recap of Strategic Activities in Joint Replacement
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin...
2014: A Recap of Strategic Activities in Orthobiologics
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin...
2014: A Recap of Strategic Activities in Spine
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin...
BARE BONES® - December 4, 2014
Medtronic received clearance from the Chinese Ministry of Commerce and the South Korean Fair Trade Commission for its proposed acquisition of Covidien. All necessary antitrust clearances have...
BARE BONES® - November 28, 2014
The European Commission conditionally cleared Medtronic's proposed acquisition of Covidien. The transaction is expected to close in early 2015. (
BARE BONES® - November 26, 2014
Medtronic received U.S. Federal Trade Commission clearance of the company's proposed acquisition of Covidien. This clearance follows Medtronic's and Covidien's agreement to a...
BARE BONES® - November 18, 2014
For FY2Q15 (ended 10/24/14), Medtronic reported spinal revenue of US $746MM, +1% from 2Q14. (U.S. $517MM, flat; ex-U.S. $229MM, +3%) (Core Spine $551MM, flat; Interventional S...
3Q14 Revenue: Medtronic
(for period ended 10/24/14) $746MM, +1% (U.S. $517MM, flat; ex-U.S. $229MM, +3%) Core Spine $551MM, flat Interventional Spine $75MM, -5% BMP $120MM, +9%   In the process of launching Prestige L...
3Q14 Revenue: Bacterin
$8.4MM, +7% OsteoSponge bone void filler represents ~60% of trailing revenue, OsteoSelect DBM putty ~17% In early 4Q, launched 3Demin (demineralized) line for procedures requiring larger volume of bone graft; Boat and Strip configurations targeted for complex...
BARE BONES® - October 21, 2014
Medtronic commenced U.S. launch of the DIVERGENCE™ Anterior Cervical Fusion system for the treatment of 1-level disc disease. DIVERGENCE supports simultaneous insertion of plate ...
BARE BONES® - October 20, 2014
Medtronic commenced launch of the Pure Titanium Coating platform of interbody fusion devices, including the CAPSTONE PTC™ and CLYDESDALE PTC globally, ANATOMIC PEEK PTC Cervical ...
BARE BONES® - October 13, 2014
Vexim will initiate a new clinical study to support its planned 2017 application for FDA 510(k) clearance to market SpineJack®. The prospective, multicenter, randomized study will compare Spi...
BARE BONES® - September 30, 2014
Preliminary 6-month results from a study comparing Vexim's SpineJack® to Medtronic's balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures revealed near...
BARE BONES® - September 17, 2014
Medtronic launched the KYPHON Express™ II Balloon Kyphoplasty Platform, including the next-generation KYPHON® Cement Delivery System (CDS). The KYPHON Express II features a maximum pressure rati...
BARE BONES® - September 16, 2014
Ortho Kinematics entered into an agreement granting Medtronic rights to promote the Vertebral Motion Analysis (VMA) test to spine surgeons. Studies indicate that VMA may produ...
BARE BONES® - August 28, 2014
Medtronic received FDA 510(k) clearance for the SHILLA™ Growth Guidance System for the treatment of pediatric patients with severe, progressive early-onset scoliosis. SHILLA features a
BARE BONES® - August 19, 2014
Medtronic posted FY1Q15 (ended 7/25/2014) spinal revenue of US $743MM, -3% from 1Q14. (Core Spinal $552MM, -2%, BMP $110MM, -11%) (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group